A study published this month by the journal Cell Biochemistry and Function, and published online by the U.S. National Institute of Health, has found promising evidence to suggest that delta-9-tetrahydrocannabinol (THC) may provide a safe and effective treatment option for those with diabetes.
For the study; “Rats were randomly divided into four groups: control, Δ9 -THC, diabetes and diabetes + Δ9 -THC groups. Δ9 -THC was administered intraperitoneally [through injection] at 3 mg/kg/day for 7 days. Body weights and blood glucose level of rats in all groups were measured on days 0, 7, 14 and 21.”
Researchers found that treatment with THC “significantly increased pancreas glutathione levels, enzyme activities of superoxide dismutase and catalase in diabetes compared with non-treatment diabetes group.. We can suggest that Δ9 -THC may be an important agent for the treatment of oxidative damages induced by diabetes.”